THURSDAY, Dec. 9, 2021 (HealthDay News) — What do all the microbes living rent-free in your gut have to do with disease risk? Perhaps a lot. A groundbreaking analysis of decades-old stool and blood samples from the early AIDS epidemic suggests that men who had high levels of inflammation-causing bacteriaContinue Reading
WEDNESDAY, Dec. 8, 2021 (HealthDay News) — When a woman’s periods begin to slow down and finally stop, digestive problems often pick up — and new research suggests race and ethnicity play a role. With menopause, levels of estrogen decrease, while cortisol levels increase, triggering an adrenaline boost that changesContinue Reading
MONDAY, Dec. 6, 2021 (HealthDay News) — New research offers fresh proof that the COVID-19 pandemic delayed cancer diagnoses in the United States, increasing patients’ risk for poor outcomes. For the study, researchers analyzed data from more than 9 million patients at over 1,200 Veterans Affairs (VA) medical facilities. ProceduresContinue Reading
FRIDAY, Nov. 19, 2021 (HealthDay News) — President Joe Biden underwent a routine colonoscopy on Friday, and briefly transferred power to Vice President Kamala Harris while he was sedated for the procedure, the White House said. The colonoscopy was part of Biden’s first routine physical exam as president, and tookContinue Reading
TUESDAY, Nov. 16, 2021 (HealthDay News) — Ten people in seven states have been sickened in an E. coli outbreak linked to baby spinach, the U.S. Centers for Disease Control and Prevention said Monday. The agency said people should not eat, sell or serve Josie’s Organics prepackaged baby spinach thatContinue Reading
MONDAY, Nov. 15, 2021 (HealthDay News) — CT scans expose patients to radiation even as they help doctors spot serious health problems. Now a new study finds low-dose scans can readily spot appendicitis while reducing patients’ radiation exposure. “The results of this study suggest that the diagnostic CT scan radiationContinue Reading
THURSDAY, Nov. 4, 2021 (HealthDay News) — Here’s some comforting news for people who struggle with inflammatory bowel disease and worry that the immune-suppressing drugs they must take might blunt their response to COVID-19 vaccines: New research finds vaccination triggers a strong immune reaction in these patients. “At eight weeks,Continue Reading
THURSDAY, Oct. 28, 2021 (HealthDay News) — Younger patients with advanced colon cancer don’t live longer than older patients, but it’s unclear why, researchers say. The authors of the new study said they were surprised by the findings, which come as colon cancer rates are on the rise among youngContinue Reading
TUESDAY, Oct. 26, 2021 (HealthDay News) — Antidepressants called selective serotonin reuptake inhibitors (SSRIs) are a mainstay of depression treatment, but a new study warns that taking common painkillers alongside SSRIs may raise the chances for intestinal bleeding. In a review of 10 published studies involving 6,000 patients, researchers foundContinue Reading
TUESDAY, Oct. 19, 2021 (HealthDay News) — While they’re helping to ease reflux, some heartburn drugs may also be reducing the severity of gum disease, new research suggests. For the study, researchers assessed probing depth in the gums (the gap between teeth and gums) in more than 1,000 patients withContinue Reading
TUESDAY, Oct. 12, 2021 (HealthDay News) — Patients who undergo surgery for certain types of cancer may have better short-term survival if they receive a particular anti-nausea drug, a preliminary study suggests. Among more than 74,000 patients who had cancer surgery, researchers found that those who received the drug —Continue Reading
WEDNESDAY, Oct. 6, 2021 (HealthDay News) — If you often have a stomachache after eating, you’re not alone, a new survey finds. One in 10 people experience frequent meal-related pain. This includes 13% of women and 9% of men, and is most common in 18- to 28-year-olds (15%), according toContinue Reading
MONDAY, Oct. 4, 2021 (HealthDay News) — Colon cancer numbers dropped dramatically during the COVID-19 pandemic, but that doesn’t mean fewer people have the disease. In Spain, researchers discovered a more than 40% decline in colon cancer diagnoses, leading experts to worry about the ramifications. “These are very worrying findingsContinue Reading
WEDNESDAY, Sept. 29, 2021 (HealthDay News) — A drug previously approved for multiple sclerosis also can treat inflammatory bowel disease in some patients, a new clinical trial reports. The medication, ozanimod (Zeposia), proved effective in helping patients with ulcerative colitis, sending many into full remission, according to results being publishedContinue Reading